Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million

1d ago, source:

Conference Call and Webcast to be held April 25, 2024, at 10:00 a.m. Eastern TimeYARDLEY, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients ...

Why Is OptiNose (OPTN) Stock Up 12% Today?

on MSN ago, source:

OptiNose stock is taking off on Thursday alongside an update on XHANCE that brings heavy trading to OPTN shares this ...

Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

on MSN ago, source:

Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected ...

Optinose to Present at the Needham Virtual Healthcare Conference

22d ago, source:

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a ...

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5mon ago, source:

Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced, as required by Nasdaq ...